Stocks and Finance

Seattle Genetics

Seattle Genetics 2/13/2012

20:09 : Seattle Genetics 2011 net loss more than double over 2010, but Q4 result ... - While Seattle Genetics Inc.’s net loss for 2011 was more than double that of 2010, its net loss for the fourth quarter of 2011 was less in the same quarter a year ago. Seattle Genetics reported its net loss ...
Source : bizjournals-com

Seattle Genetics 11/3/2011

20:11 : Seattle Genetics beats Wall Street predictions for new cancer drug - Seattle Genetics, Inc. had a net loss of $40.7 million for the third quarter of 2011, but the company benefited from the recent launch of new cancer drug Adcetris. Third quarter revenues were $20.7 million this year, compared to ...
Source : bizjournals-com

Seattle Genetics 10/21/2011

18:04 : Analyst: Seattle Genetics should outperform forecasts - Seattle Genetics Inc. should far exceed Wall Street forecasts for its performance when it releases third quarter financial results Nov. 3, according to Thomas Wei, an analyst with Jefferies & Co., Xconomy reported. ...
Source : bizjournals-com

Seattle Genetics 10/7/2011

19:32 : Zishen Fan sentenced to 18 months in Seattle Genetics insider trading ... - Zishen Fan, the brother of an employee of Seattle Genetics Inc. who allegedly profited by his inside knowledge of the successful trial of one of the biotech's cancer drugs, was sentenced today in U.S. District Court in Seattle ...
Source : bizjournals-com

Seattle Genetics 8/19/2011

13:56 : FDA approves Seattle Genetics drug for 2 cancers - WASHINGTON (AP) -- Federal regulators have approved an innovative cancer drug from Seattle Genetics Inc. to treat two rare forms of cancer that attack the lymph nodes....
Source : usnews-com

Seattle Genetics 7/15/2011

09:31 : Seattle Genetics slides 11% on drug launch worries - BOSTON (MarketWatch) -- Shares of Seattle Genetics fell 11% to $18.09 on concerns that the U.S. launch of its new oncology drug Adcentris might be delayed because of a regulatory snag. On Thursday, an advisory panel of the U.S. ...
Source : marketwatch-com

Seattle Genetics 6/17/2011

19:16 : Seattle Genetics promotes Eric Dobmeier to COO - Seattle Genetics announced Friday that Eric Dobmeier has been promoted to the newly created position of chief operating officer. Dobmeier has worked with the Bothell-based biotech for nine years, most recently as chief business ...
Source : bizjournals-com

Seattle Genetics 6/16/2011

18:48 : FDA to review Seattle Genetics cancer drug applications in July - Seattle Genetics Inc. announced that the U.S. Food and Drug Administration's Oncologic Drugs Advisory Committee (ODAC) will review two of its applications for its cancer drug brentuximab vedotin on July 14. the Bothell biotech ...
Source : bizjournals-com
actualidad Seattle Genetics -


Biotechnology

Pharmaceuticals

Medical Supplies

Medical Equipment

Health Care Providers

Copyright © 2009 Finaperf.com - Exchange rate - Investir - Stock Exchange - Börse - Finanças - Bolsa - Tous droits réservés
Site édité par Yanga.net - Contacts